69 related articles for article (PubMed ID: 35116576)
1. Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma.
Berendsen MR; van Bladel DAG; Hesius E; Berganza Irusquieta C; Rijntjes J; van Spriel AB; van der Spek E; Pruijt JFM; Kroeze LI; Hebeda KM; Croockewit S; Stevens WBC; van Krieken JHJM; Groenen PJTA; van den Brand M; Scheijen B
Hemasphere; 2023 Nov; 7(11):e976. PubMed ID: 37928625
[TBL] [Abstract][Full Text] [Related]
2. Toripalimab plus lenalidomide for central nervous system recurrence in refractory CD5
Chen X; Zhang Z; Zhang J; Yu Q; Qiu J; Xiao Y; Chen B; Xu P
Transl Cancer Res; 2024 Feb; 13(2):1188-1195. PubMed ID: 38482415
[TBL] [Abstract][Full Text] [Related]
3. Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.
Shen R; Xu PP; Wang N; Yi HM; Dong L; Fu D; Huang JY; Huang HY; Janin A; Cheng S; Wang L; Zhao WL
Clin Transl Med; 2020 Nov; 10(7):e221. PubMed ID: 33252851
[TBL] [Abstract][Full Text] [Related]
4. Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated
Liu Y; Ma X; Wu X; Hou X; Jin W; Fu L; Xun X; Yu Y; Shen Z
Leuk Lymphoma; 2024 May; ():1-11. PubMed ID: 38775302
[TBL] [Abstract][Full Text] [Related]
5. A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1.
Zhang X; Su Q; Zhang Y; Rong R; Chen S; He L; Zhuang W; Li B
Ann Hematol; 2024 Mar; ():. PubMed ID: 38424303
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice.
Visco C; Tanasi I; Quaglia FM; Ferrarini I; Fraenza C; Krampera M
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050534
[TBL] [Abstract][Full Text] [Related]
7. CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway.
He Z; Shen S; Yi Y; Ren L; Tao H; Wang F; Jia Y
Am J Transl Res; 2023; 15(4):2656-2675. PubMed ID: 37193155
[TBL] [Abstract][Full Text] [Related]
8. Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies.
Magnes T; Wagner S; Thorner AR; Neureiter D; Klieser E; Rinnerthaler G; Weiss L; Huemer F; Schlick K; Zaborsky N; Steiner M; Greil R; Egle A; Melchardt T
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33561953
[TBL] [Abstract][Full Text] [Related]
9. Conformational transitions in BTG1 antiproliferative protein and their modulation by disease mutants.
Kots E; Mlynarczyk C; Melnick A; Khelashvili G
Biophys J; 2022 Oct; 121(19):3753-3764. PubMed ID: 35459639
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma.
Xing C; Zhu S; Yan W; Zhu H; Huang Z; Zhao Y; Guo W; Zhang H; Yin L; Ruan X; Deng Z; Wang P; Cheng Z; Wang Z; Peng H
Heliyon; 2023 Nov; 9(11):e22209. PubMed ID: 38045198
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Huang Z; Wang K; Huang S; Lu Q
Transl Cancer Res; 2023 Aug; 12(8):2169-2180. PubMed ID: 37701105
[TBL] [Abstract][Full Text] [Related]
12. Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract][Full Text] [Related]
13. Prevalence And Clinical Significance Of Oncogenic
Chen YP; Ke LF; Lu JP; Wang JC; Zhu WF; Chen FF; Lin SF; Xu CW; Wu MJ; Chen G
Onco Targets Ther; 2019; 12():10165-10175. PubMed ID: 32063711
[TBL] [Abstract][Full Text] [Related]
14. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
[TBL] [Abstract][Full Text] [Related]
15. Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma.
Dobashi A
J Clin Exp Hematop; 2016; 56(2):71-78. PubMed ID: 27980305
[TBL] [Abstract][Full Text] [Related]
16. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
17. Identification of key mutations in central nervous diffuse large B-cell lymphoma (DLBCL) by comprehensive analysis between sequencing and TCGA database.
Zhou C; Cui Y; Sun H; Yang F; Zhao H; Huangfu L; Zhang J
Transl Cancer Res; 2021 Jun; 10(6):2632-2642. PubMed ID: 35116576
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]